VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $267,000 | +12.2% | 1,200 | 0.0% | 0.14% | +9.4% |
| Q1 2015 | $238,000 | -89.7% | 1,200 | -93.4% | 0.13% | -90.1% |
| Q2 2014 | $2,309,000 | -4.8% | 18,304 | -0.5% | 1.28% | -11.1% |
| Q1 2014 | $2,425,000 | +12.3% | 18,393 | 0.0% | 1.44% | +10.6% |
| Q4 2013 | $2,159,000 | +13.0% | 18,393 | +0.5% | 1.31% | -0.4% |
| Q3 2013 | $1,910,000 | +20.7% | 18,304 | -0.5% | 1.31% | +19.0% |
| Q2 2013 | $1,583,000 | – | 18,393 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |